News & Industry Updates

Press Releases Jul 28, 2025

ReAlta Life Sciences Strengthens Management Team with the Appointment of Biotechnology Business...

Accomplished biopharma executive brings nearly 25 years of experience in business development, capital formation, and enterprise strategy to this role...

Read More
Press Releases Jul 22, 2025

ReAlta Life Sciences Publishes Data Demonstrating RLS-0071 (pegtarazimod) Reduces Brain Inflammation in...

Study shows pegtarazimod reduces microglial activation associated with pathogenic neuroinflammation in hypoxic ischemic encephalopathy, as well as neurodegenerative diseases such...

Read More
Press Releases May 19, 2025

ReAlta Life Sciences Announces New Inflammatory Biomarker Data from Acute Exacerbations of...

NORFOLK, Va.–ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the...

Read More
Press Releases Apr 25, 2025

ReAlta Life Sciences Announces New Clinical Data for RLS-0071 (pegtarazimod) from Hypoxic...

Data confirm elevated inflammatory biomarkers in newborns with Hypoxic Ischemic Encephalopathy (HIE) and demonstrate a predictable pharmacokinetic profile for RLS-0071...

Read More
Press Releases Apr 08, 2025

ReAlta Life Sciences to Present New Clinical Data from Hypoxic Ischemic Encephalopathy...

NORFOLK, Va.–ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the...

Read More
Press Releases Apr 01, 2025

ReAlta Life Sciences Announces Appointment of Distinguished Immunologist, Laurie Glimcher, M.D., to...

NORFOLK, Va.–ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the...

Read More
Press Releases Feb 25, 2025

ReAlta Life Sciences Announces Appointment of Biotechnology Leader Andrew Miller, Ph.D., to...

NORFOLK, Va. – February 25, 2025 – ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated...

Read More
Press Releases Dec 08, 2024

ReAlta Life Sciences Announces Positive Preclinical Data for RLS-0071 (pegtarazimod) in Acute...

Data demonstrates pegtarazimod’s ability to reduce inflammation and significantly increase survival rates in multiple preclinical models of aGVHD Norfolk, Va...

Read More
Press Releases Nov 21, 2024

ReAlta Announces Appointment of Distinguished Biopharmaceutical Leader Lewis T. “Rusty” Williams, MD,...

Norfolk, VA, November 21, 2024 – ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to...

Read More